h h h h
ductoryClinical Pharmacolo h
gy 11th edition- h h
comprehensive-2022-2023
h
1. Ahnursinghinstructorhishpreparinghahteachinghplanhforhahgrouphofhnursinghstudentshabouthp
harmacology.hWhenhdescribinghthishtopic,hthehinstructorhwouldhfocushthehdiscussionhonhw
hichhofhthehfollowinghashanhessentialhaspect?
A) Drughname
B) Drughclass
C) Drughaction
D) Drughsourceh
Ans:h ChFeedbac
k:
Pharmacologyhishthehstudyhofhdrugshandhtheirhactionhonhlivinghorganisms.hThus,hanhessenti
alhaspecthofhpharmacologyhishdrughaction.hAnhunderstandinghofhthehdrughname,hdrughclass,h
andhdrughsourcehishimportant,hbuththehmosthcriticalhaspecthrelatedhtohpharmacologyhishhowh
thehdrughactshinhthehbody.
2. Ahnursinghstudenthishpreparinghtohadministerhahprescribedhdrughtohahpatient.hThehstudenthre
viewshinformationhabouththehdrughandhitshactions.hWhichhofhthehfollowinghwouldhbehthehbes
thchoicehforhobtaininghthishinformation?h Selecthallhthathapply.
A) Nursinghinstructor
B) Nursehassignedhtohthehpatient
C) Clinicalhdrughreference
D) Prescribinghhealthhcarehprovider
E) Clinicalhpharmacisth
Ans:h C,hE
Feedback:
Althoughhthehnursinghstudenthcanhaskhthehnursinghinstructor,hthehnursehassignedhtohthehpati
ent,handhthehprescribinghhealthhcarehproviderhforhinformationhabouththehdrug,hthehbesthchoic
eshforhdrughinformationhwouldhincludehanhappropriatehdrughreferencehandhthehclinicalhphar
macist.
3. Whenhdescribinghthehvarioushtypeshofhmedicationshtohahgrouphofhnursinghstudents,hahn
ursinghinstructorhwouldhidentifyhwhichhofhthehfollowinghashahsourcehforhderivinghme
dications?hSelecthallhthathapply.
A) Plants
B) Synthetichsources
C) Mold
D) Minerals
E) Animals
Pageh 1
,Ans:hA,hB,hC,hD,hE
Feedback:
Medicationsharehderivedhfromhnaturalhsources,hforhexample,hplants,hmolds,hminerals,handha
nimals,hashwellhashcreatedhsyntheticallyhinhahlaboratory.
Pageh 2
,TestBank for Roach’s IntroductoryC
h h h h
linical Pharmacology 11th edition10
h h h h
0 correct answered
h h
4. Whichhofhthehfollowinghnameshmayhbehassignedhtohahdrughduringhthehprocesshofhd
evelopment?hSelecthallhthathapply.
A) Chemicalhname
B) Officialhname
C) Pharmacologichname
D) Tradehname
E) Nonproprietaryhnameh
Ans:h A,hB,hD,hEhFeedback
:
Throughouththehprocesshofhdevelopment,hdrugshmayhhavehseveralhnameshassignedhtohthem
hincludinghahchemicalhname,hahgenerich(nonproprietary)hname,hanhofficialhname,handhahtrade
horhbrandhname.
5. Ahdrughmayhbehclassifiedhbyhwhichhofhthehfollowing?h Selecthallhthathapply.
A) Thehchemicalhtypehofhthehdrug'shactivehingredient
B) Thehwayhthehdrughishusedhtohtreathahspecifichcondition
C) Thehgenerichnamehofhthehdrug
D) Thehtradehnamehofhthehdrug
E) Thehnonproprietaryhnamehofhthehdrugh
Ans:h A,hB
Feedback:
Ahdrughmayhbehclassifiedhbyhthehchemicalhtypehofhthehactivehingredienthorhbyhthehwayhithishu
sedhtohtreathahparticularhcondition.hGeneric,htrade,handhnonproprietaryhreferhtohhowhahdrughi
shnamed.
6. Ahgrouphofhnursinghstudentsharehreviewinghinformationhabouththehprocesshofhdrughdeve
lopmenthinhthehUnitedhStates.hThehstudentshdemonstratehunderstandinghofhthishprocessh
whenhtheyhidentifyhthathwhichhofhthehfollowinghcategoriesharehassignedhbyhthehFoodhand
hDrughAdministrationhtohnewlyhapprovedhdrugs? hSelecthallhthathapply.
A) Metabolite
B) Noncontrolledhsubstance
C) Prescription
D) Nonprescription
E) Controlledhsubstanceh
Ans:h C,hD,hE
Feedback:
Oncehdrugsharehapprovedhforhuse,hthehFDAhassignshthehdrughtohonehofhthehfollowinghcateg
ories:hprescription,hnonprescription,horhcontrolledhsubstance.hMetabolitehrefershtohthehinact
ivehformhofhthehdrug.hNoncontrolledhsubstancehishahtermhthathishnothused.
Pageh 3
, TestBank for Roach’s IntroductoryC
h h h h
linical Pharmacology 11th edition10
h h h h
0 correct answered
h h
7. Whichhofhthehfollowinghwouldhbehmosthimportanthforhthehnursehtohdohtohensurehthehsafehu
sehofhprescriptionhdrugshinhthehinstitutionalhsetting?hSelecthallhthathapply.
A) Administeringhdrugs
B) Monitoringhclientshforhdrugheffects
C) Prescribinghdrugs
D) Evaluatinghclientshforhtoxicheffects
E) Educatinghclients/caregivershabouthdrugsh
Ans:h A,hB,hD,hE
Feedback:
Inhthehinstitutionalhsetting,hthehnurse'shrolehtohensurehsafehusehofhprescriptionhdrugshinclude
shadministeringhdrugs,hmonitoringhdrugheffects,hevaluatinghforhtoxicheffects,handheducatingh
clientshandhcaregivershabouthdrugs.
8. Thehnursehishhelpinghahclienthreviewhahprescriptionhfromhthehhealthhcarehprovider.hWhenhe
xamininghthehprescription,hwhichhofhthehfollowinghwouldhthehnursehexpecthtohfindhdocu
mented?hSelecthallhthathapply.
A) Namehofhthehdrug
B) Dosagehofhthehdrug
C) Routehofhdrughadministration
D) Timeshofhdrughadministration
E) Licensedhprescriber'shsignatureh
Ans:h A,hB,hC,hD,hE
Feedback:
Thehprescriptionhmusthcontainhthehclient'shname,hthehnamehofhthehdrug,hthehdosage,hthehmet
hodhandhtimeshofhadministration,handhthehsignaturehofhthehlicensedhhealthhcarehproviderhpr
escribinghthehdrug.
9. Afterhteachinghahgrouphofhnursinghstudentshabouthnonprescriptionhdrugs,hthehnursinghinst
ructorhdetermineshthaththehteachinghwashsuccessfulhwhenhthehstudentshidentifyhwhichhofhth
ehfollowing?hSelecthallhthathapply.
A) Theyhrequirehahlicensedhhealthhcarehprovider'shsignature.
B) Theyharehreferredhtohashover-the-counterhdrugs.
C) Theyhcanhbehtakenhwithouthriskhtohthehclient.
D) Theyhhavehcertainhlabelinghrequirements.
E) Theyhshouldhbehtakenhonlyhashdirectedhonhthehlabel.h
Ans:h B,hD,hE
Feedback:
Nonprescriptionhdrugsharehoftenhreferredhtohashover-the-
counterh(OTC)hdrugs.hTheyhdohnothrequirehahprescriptionh(ahlicensedhhealthhcarehprovider'
shsignature)hbuthdohnothcomehwithouthriskhtohthehclient.hThehfederalhgovernmenthhashimpos
edhlabelinghrequirementshofhOTChdrugshandhtheyhshouldhonlyhbehtakenhashdirectedhonhthehl
abelhunlesshunderhthehsupervisionhofhahhealthhcarehprovider.
Pageh 4